Ohio State researchers are working with patients to develop comprehensive treatment for depression and anxiety that results from advanced lung cancer. The ABC — or A biobehavioral cognitive — study currently underway at the OSUCCC – James is aimed at reducing moderate to severe depression and/or anxiety by addressing behavioral, cognitive and biological aspects of patients’ lives during lung cancer treatment. The study, which is open to Ohio State patients with non-small-cell lung cancer, has already shown promise, according to researcher Nicole Arrato, MA. “Most of our patients start in the moderate range, where symptoms are really getting in the way of their functioning,” Arrato says. “By the end of treatment, some of those symptoms have been reduced to mild, or even non-existent, ranges. We know that there's no routine lung cancer, so we need to support each patient's needs and recognize their strengths.”